Dual target blockade may be better than one in SLE Inhibition of B-cell Activating Factor (BAFF) has revolutionised the treatment of patients with systemic lupus erythematosus (SLE). https://t.co/uu6ygb4l8B https://t.co/nLO3oSiEVa